IMMUCOR ITALIA S.P.A.
IMMUCOR ITALIA S.P.A. is a federal contractor, registered under UEI VXJRVAYZFTK3 and CAGE code A0989. It has been awarded $39,113 in federal contracts. Primary work spans In-Vitro Diagnostic Substance Manufacturing. Top awarding agencies include Department Of Defense.
Contact Information
Registration and classification details
Registration
UEI Code
VXJRVAYZFTK3CAGE Code
A0989Entity Structure
OtherEstablished
N/ABusiness Classifications
NAICS Codes
Federal Contracting Overview
Award totals, agency breakdown, NAICS distribution, and geographic footprint.
AI Capability Profile
Immucor Italia S.P.A. specializes in the manufacturing of in-vitro diagnostic substances, delivering critical reagents and assay systems used in blood typing, immunohematology, and transfusion safety applications. Their technical expertise centers on high-precision biological reagent formulation, qu...
Immucor Italia S.P.A. specializes in the manufacturing of in-vitro diagnostic substances, delivering critical reagents and assay systems used in blood typing, immunohematology, and transfusion safety applications. Their technical expertise centers on high-precision biological reagent formulation, quality-controlled production of monoclonal antibodies, and regulatory-compliant manufacturing of diagnostic kits for clinical and military blood screening. The company’s key differentiator lies in its ability to produce standardized, stable, and highly specific reagents for automated and manual immunoassay platforms, ensuring reliability in low-resource and high-throughput environments. Their products support serological testing workflows essential for donor screening, patient compatibility testing, and transfusion medicine. The contractor has delivered diagnostic solutions to the Department of Defense, providing mission-critical reagents used in military medical facilities for blood bank operations and combat casualty care. These engagements reflect a consistent focus on supplying robust, field-deployable diagnostic substances that meet stringent military specifications for stability, traceability, and rapid deployment under austere conditions. Immucor Italia operates within the in-vitro diagnostic substance manufacturing sector (NAICS 325413), a niche domain requiring GMP-grade production, sterile processing, and adherence to ISO 13485 and FDA standards for medical devices. The company’s vertical specialization is in immunohematology diagnostics, serving laboratories that require precise antigen-antibody detection systems for transfusion safety and hemolytic disease prevention. As a limited liability entity headquartered in Milan, Italy, Immucor Italia S.P.A. maintains a focused geographic footprint with no active U.S. government certifications. Its government market positioning is defined by its capacity to supply certified diagnostic reagents to U.S. defense medical logistics channels, leveraging its European manufacturing infrastructure to support global military health requirements.
Key Performance Metrics
Awards Count
5
All time
Active
0
Currently performing
Completed
5
Past period of performance
Total Awards
All time
Contracts
Prime · all time
Subcontracts
Sub · all time
Grants
Prime · all time
Subgrants
Sub · all time
Award Analytics & Distribution
Compete with IMMUCOR ITALIA S.P.A.
Track the contractors you bid against, and the work they win
Award history, agency mix, and NAICS coverage for IMMUCOR ITALIA S.P.A.
AI-powered matching against your own capabilities and past performance
Teaming and subcontracting signals on every award
Automated alerts when a competitor wins in your market
Join 750+ contractors already using CLEATUS
